BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 28255348)

  • 1. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
    Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
    Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted Drug Delivery by Nanocomposites.
    Baker A; Khan MS; Iqbal MZ; Khan MS
    Curr Drug Metab; 2020; 21(8):599-613. PubMed ID: 32433002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
    He B; Sui X; Yu B; Wang S; Shen Y; Cong H
    Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
    Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
    Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive drug-delivery systems for tumor targeting.
    He X; Li J; An S; Jiang C
    Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme responsive drug delivery systems in cancer treatment.
    Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments.
    Sun T; Jiang C
    Adv Drug Deliv Rev; 2023 May; 196():114773. PubMed ID: 36906230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-stimuli responsive hollow MnO
    Xu X; Duan J; Liu Y; Kuang Y; Duan J; Liao T; Xu Z; Jiang B; Li C
    Acta Biomater; 2021 May; 126():445-462. PubMed ID: 33785453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges.
    Zhang M; Guo X; Wang M; Liu K
    J Control Release; 2020 Jul; 323():203-224. PubMed ID: 32320817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
    Wang J; Sui M; Fan W
    Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications.
    Duan L; Yang L; Jin J; Yang F; Liu D; Hu K; Wang Q; Yue Y; Gu N
    Theranostics; 2020; 10(2):462-483. PubMed ID: 31903132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
    Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
    Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermia and smart drug delivery systems for solid tumor therapy.
    Seynhaeve ALB; Amin M; Haemmerich D; van Rhoon GC; Ten Hagen TLM
    Adv Drug Deliv Rev; 2020; 163-164():125-144. PubMed ID: 32092379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.